Showing results (281-290 of 758) with videos related to

Sort By:
Pageof 76
The Lancet. Gastroenterology & Hepatology|December 7, 2023
Endoscopic ultrasonography-guided gastroenterostomy versus uncovered duodenal metal stenting for unresectable malignant gastric outlet obstruction (DRA-GOO): a multicentre randomised controlled trialAnthony Yuen Bun Teoh, Sundeep Lakhtakia, Ilaria Tarantino, et al.
The Lancet. Gastroenterology & Hepatology|November 12, 2023
Effect of an artificial intelligence-assisted system on endoscopic diagnosis of superficial oesophageal squamous cell carcinoma and precancerous lesions: a multicentre, tandem, double-blind, randomised controlled trialXiang-Lei Yuan, Wei Liu, Yi-Xiu Lin, et al.
The Lancet. Gastroenterology & Hepatology|November 6, 2023
Genetic predisposition to gastrointestinal polyposis: syndromes, tumour features, genetic testing, and clinical managementLaura Valle, Kevin J Monahan
The Lancet. Gastroenterology & Hepatology|July 18, 2024
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trialEline M L van der Does de Willebois, Vittoria Bellato, Marjolijn Duijvestein, et al.
The Lancet. Gastroenterology & Hepatology|July 21, 2024
An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trialOswaldo Ortiz, Maria Daca-Alvarez, Liseth Rivero-Sanchez, et al.
The Lancet. Gastroenterology & Hepatology|May 18, 2024
Duration of risk reduction in colorectal cancer incidence and mortality after a complete colonoscopy in Ontario, Canada: a population-based cohort studyArlinda Ruco, Rahim Moineddin, Rinku Sutradhar, et al.
The Lancet. Gastroenterology & Hepatology|October 8, 2023
Safety and efficacy of once-daily HU6 versus placebo in people with non-alcoholic fatty liver disease and high BMI: a randomised, double-blind, placebo-controlled, phase 2a trialMazen Noureddin, Shaharyar Khan, Francisco Portell, et al.
The Lancet. Gastroenterology & Hepatology|October 22, 2023
The immunological landscape in pancreatic ductal adenocarcinoma and overcoming resistance to immunotherapyMarc Hilmi, Matthieu Delaye, Milena Muzzolini, et al.
The Lancet. Gastroenterology & Hepatology|September 21, 2023
Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trialJohn V Reynolds, Shaun R Preston, Brian O'Neill, et al.
The Lancet. Gastroenterology & Hepatology|January 28, 2019
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours (LEOPARD-2): a multicentre, patient-blinded, randomised controlled phase 2/3 trialJony van Hilst, Thijs de Rooij, Koop Bosscha, et al.
Pageof 76